Conversion of human fibroblasts into multipotent cells by cell-penetrating peptides

被引:3
|
作者
Kikuchi, Jiro [1 ]
Hayashi, Nakanobu [2 ]
Osada, Naoki [1 ]
Sugitani, Masahiko [3 ,4 ]
Furukawa, Yusuke [1 ]
机构
[1] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Gene Try Co, Itabashi Ku, Tokyo 1738610, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738610, Japan
[4] Ageo Cent Gen Hosp, Pathol Div, Ageo, Saitama 3628588, Japan
关键词
Cell-penetrating peptide; Multipotent cell; Histone deacetylase; Lysine specific demethylase 1; Regenerative medicine; PLURIPOTENT STEM-CELLS; DELIVERY; GENE; INDUCTION; VECTOR; LSD1;
D O I
10.1016/j.bbrc.2019.08.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential application of human induced pluripotent stem cells (hiPSCs) brings great expectations to regenerative medicine. However, several safety concerns, such as oncogenic transformation, remain. A number of methods have been developed to produce hiPSCs with potentially reduced risks. Cell-penetrating peptides (CPPs) are expected to improve the efficiency of nonviral reprogramming by delivering biologically active molecules into cells. Here, we show that the transfection of CPPs alone into normal adult human fibroblasts generated embryonic body (EB)-like cell clusters in the absence of reprogramming factors. The CPP-generated cell clusters were positive for a set of multipotency markers and differentiated into endodermal, ectodermal, and mesodermal cells in vitro. These results suggest that CPPs converted normal human adult somatic cells into multipotent cells. Moreover, we show that CPPs dissociated histone deacetylase 1 and lysine-specific demethylase 1 from the promoter/enhancer regions of reprogramming factors to reactivate their expression. This is the first report of an easy and quick method for somatic cell reprogramming by CPPs and a novel mechanism of reprogramming. The potential application of CPP-generated multipotent cells resolves several concerns, especially safety issues, in regenerative medicine. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [41] siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells
    Li, Hua
    He, Jiwen
    Yi, Huimin
    Xiang, Guoan
    Chen, Kaiyun
    Fu, Binsheng
    Yang, Yang
    Chen, Guihua
    BIOSCIENCE REPORTS, 2015, 35
  • [42] AI-Driven Design of Cell-Penetrating Peptides for Therapeutic Biotechnology
    Ma, Hongru
    Zhou, Xinzhi
    Zhang, Ziyue
    Weng, Zhaocheng
    Li, Guo
    Zhou, Yuqiao
    Yao, Yuan
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2024, 30 (06)
  • [43] Transdermal Properties of Cell-Penetrating Peptides: Applications and Skin Penetration Mechanisms
    Shin, Hee Je
    Lee, Byung Kyu
    Kang, Hyun Ah
    ACS APPLIED BIO MATERIALS, 2023, 7 (01) : 1 - 16
  • [44] Cell-penetrating proteins and peptides as a promising theragnostic agent for neurodegenerative disorder
    Pancholi, Bhaskaranand
    Choudhary, Mayank Kumar
    Kumar, Manoj
    Babu, Raja
    Vora, Lalitkumar K.
    Khatri, Dharmendra Kumar
    Garabadu, Debapriya
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 107
  • [45] Intrinsically Disordered Ku Protein-Derived Cell-Penetrating Peptides
    Maity, Biswanath
    Moorthy, Hariharan
    Govindaraju, Thimmaiah
    ACS BIO & MED CHEM AU, 2023, 3 (06): : 471 - 479
  • [46] Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling
    Kilk, Kalle
    Mahlapuu, Riina
    Soomets, Ursel
    Langel, Ulo
    TOXICOLOGY, 2009, 265 (03) : 87 - 95
  • [47] Structural Development of Cell-Penetrating Peptides Containing Cationic Proline Derivatives
    Kobayashi, Hiroyuki
    Misawa, Takashi
    Oba, Makoto
    Hirata, Naoya
    Kanda, Yasunari
    Tanaka, Masakazu
    Matsuno, Kenji
    Demizu, Yosuke
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (05) : 575 - 580
  • [48] Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides
    Ishihara, Tsutomu
    Goto, Maoko
    Kodera, Kanae
    Kanazawa, Hideko
    Murakami, Yasuko
    Mizushima, Yutaka
    Higaki, Megumu
    DRUG DELIVERY, 2009, 16 (03) : 153 - 159
  • [49] Cell-penetrating and cell-targeting peptides in drug delivery
    Vives, Eric
    Schmidt, Julien
    Pelegrin, Andre
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1786 (02): : 126 - 138
  • [50] Cyclic Cell-Penetrating Peptides with Single Hydrophobic Groups
    Song, Jian
    Qian, Ziqing
    Sahni, Ashweta
    Chen, Kuangyu
    Pei, Dehua
    CHEMBIOCHEM, 2019, 20 (16) : 2085 - 2088